Phase 1 HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to give their agreement to take part in the study (informed consent)
- People who are 18 years of age or older
- People who have been diagnosed with high-grade anal dysplasia (a type of abnormal cell growth in the anal area), confirmed by a tissue biopsy
- People who are willing to follow all study procedures throughout the trial
Who may not be able to join:
- People who have been diagnosed with low-grade anal dysplasia (a less severe form of abnormal cell changes in the anal area), as identified by a specialised examination procedure
- People whose immune cell count (specifically CD4 cells) is below 200 cells per cubic millimetre of blood at the time the trial site considers them for entry
- People who are unable to give their agreement to take part in the study
- People who are pregnant or currently breastfeeding
- People who are currently receiving chemotherapy or radiation treatment for another cancer
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Evie Carchman, MD, FACS, University of Wisconsin, Madison
Phone: 800-622-8922
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Maximum Tolerated Dose (MTD) as determined by the number of participants at each dose level in the escalation cohorts who experienced a dose-limiting toxicity (DLT); Rate of Grade 3 or above Toxicities in any Organ System in the Escalation Cohorts
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.